Is it Fair to Contraindicate Cardiac Defibrillator Implantation for Patients with Socioeconomic or Psychological Vulnerability?
作者信息
Monteiro Marcelo de Paula Martins, Brasil Helena Nogueira, Rodrigues Sobrinho Carlos Roberto Martins, Rocha Eduardo Arrais
机构信息
Faculdade de Medicina da Universidade Federal do Ceará - Cardiologia, Fortaleza, CE - Brasil.
Universidade Federal do Ceará - Hospital Universitário Walter Cantídio, Fortaleza, CE - Brasil.
出版信息
Arq Bras Cardiol. 2024 Dec 2;121(10):e20240643. doi: 10.36660/abc.20240643. eCollection 2024.
Abstract
摘要
相似文献
1
Is it Fair to Contraindicate Cardiac Defibrillator Implantation for Patients with Socioeconomic or Psychological Vulnerability?对具有社会经济或心理脆弱性的患者禁忌植入心脏除颤器是否公平？
Arq Bras Cardiol. 2024 Dec 2;121(10):e20240643. doi: 10.36660/abc.20240643. eCollection 2024.
2
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).大多数植入式心脏复律除颤器/心脏再同步治疗除颤器患者可行无诱导或有限电击测试：多中心ASSURE研究（心律失常单次电击除颤阈值测试与易损性上限：植入式心脏复律除颤器植入的风险降低评估）结果
Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30.
3
Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.植入式心脏复律除颤器与2001年至2012年丹麦急性心肌梗死所致院外心脏骤停后的生存率：一项全国性研究
Eur Heart J Acute Cardiovasc Care. 2017 Mar;6(2):144-154. doi: 10.1177/2048872616687115. Epub 2017 Jan 6.
4
Association between socioeconomic factors and ICD implantation in a publicly financed health care system: a Danish nationwide study.社会经济因素与公共资助医疗体系中 ICD 植入的关联：一项丹麦全国性研究。
Europace. 2018 Jul 1;20(7):1129-1137. doi: 10.1093/europace/eux223.
5
The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).心脏再同步治疗除颤器与植入式心脏复律除颤器患者中，间歇性房性快速心律失常对心力衰竭或死亡的影响：MADIT-CRT 亚研究（多中心自动除颤器植入试验与心脏再同步治疗）。
J Am Coll Cardiol. 2014 Apr 1;63(12):1190-1197. doi: 10.1016/j.jacc.2013.10.074. Epub 2013 Dec 11.
6
Trends in the use of implantable cardioverter-defibrillator and cardiac resynchronization therapy device in advancing age: Analysis of the Japan cardiac device treatment registry database.高龄人群植入式心脏复律除颤器和心脏再同步治疗设备的使用趋势：日本心脏设备治疗登记数据库分析
J Arrhythm. 2020 Jun 8;36(4):737-745. doi: 10.1002/joa3.12377. eCollection 2020 Aug.
7
8
Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).卡维地洛和美托洛尔对植入式心律转复除颤器不适当治疗的影响：MADIT-CRT 试验（心脏再同步治疗的多中心自动除颤器植入）。
J Am Coll Cardiol. 2013 Oct 8;62(15):1343-50. doi: 10.1016/j.jacc.2013.03.087. Epub 2013 Jun 13.
9
Psychological vulnerability, ventricular tachyarrhythmias and mortality in implantable cardioverter defibrillator patients: is there a link?心理脆弱性、室性心律失常与植入式心脏复律除颤器患者的死亡率：二者是否存在关联？
Expert Rev Med Devices. 2012 Jul;9(4):377-88. doi: 10.1586/erd.12.31.
10
Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).在轻度心力衰竭患者中（来自MADIT-CRT研究），植入式心律转复除颤器或心脏再同步化治疗除颤器之前心力衰竭住院对后续结局的时间影响
Am J Cardiol. 2015 May 15;115(10):1423-7. doi: 10.1016/j.amjcard.2015.02.029. Epub 2015 Feb 18.
本文引用的文献
1
Potentially Inappropriate Cardioverter Defibrillator Implants in Secondary Prevention of Death.潜在不适当的心脏复律除颤器植入在死亡二级预防中的应用。
Arq Bras Cardiol. 2024 Nov 11;121(10):e20220899. doi: 10.36660/abc.20220899. eCollection 2024.
2
Predictors of Appropriate Therapies and Death in Patients with Implantable Cardioverter-Defibrillator and Chronic Chagas Heart Disease.植入式心脏复律除颤器和慢性恰加斯心脏病患者的适当治疗和死亡预测因素。
Arq Bras Cardiol. 2024 Aug 19;121(6):e20230337. doi: 10.36660/abc.20230337. eCollection 2024.
3
Mortality Risk Stratification in Heart Failure. The Search for the Holy Grail Continues! Autonomic Nervous System Analysis is Back!心力衰竭中的死亡风险分层。对圣杯的探寻仍在继续！自主神经系统分析回归了！
Arq Bras Cardiol. 2023 Feb;120(11):e20230761. doi: 10.36660/abc.20230761.
4
Impacts of Poverty and Lifestyles on Mortality: A Cohort Study in Predominantly Low-Income Americans.贫困与生活方式对死亡率的影响：以美国低收入人群为主的队列研究。
Am J Prev Med. 2024 Jul;67(1):15-23. doi: 10.1016/j.amepre.2024.02.015. Epub 2024 Feb 27.
5
Systematic Review and Meta-Analysis of Clinical Outcome After Implantable Cardioverter-Defibrillator Therapy in Patients With Chagas Heart Disease.Chagas 心脏病患者植入式心脏复律除颤器治疗后临床结局的系统评价和荟萃分析。
JACC Clin Electrophysiol. 2019 Oct;5(10):1213-1223. doi: 10.1016/j.jacep.2019.07.003. Epub 2019 Aug 28.
6
Renal denervation as adjunctive therapy to cardiac sympathetic denervation for ablation refractory ventricular tachycardia.肾脏去神经支配作为心脏交感神经去神经支配辅助治疗消融难治性室性心动过速。
Heart Rhythm. 2020 Feb;17(2):220-227. doi: 10.1016/j.hrthm.2019.09.016. Epub 2019 Sep 17.
7
2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.2019 年 HRS/EHRA/APHRS/LAHRS 对 2015 年最佳植入式心脏复律除颤器编程和测试专家共识声明的重点更新。
Heart Rhythm. 2020 Jan;17(1):e220-e228. doi: 10.1016/j.hrthm.2019.02.034. Epub 2019 May 15.
8
Clinical Course After Cardioverter-Defibrillator Implantation: Chagasic Versus Ischemic Patients.植入心脏复律除颤器后的临床病程：恰加斯病患者与缺血性心肌病患者对比
Arq Bras Cardiol. 2016 Aug;107(2):99-100. doi: 10.5935/abc.20160101. Epub 2016 Jul 11.
9
Long-term follow-up of patients with chronic chagas disease and implantable cardioverter-defibrillator.慢性恰加斯病患者与植入式心脏复律除颤器的长期随访
Pacing Clin Electrophysiol. 2014 Jun;37(6):751-6. doi: 10.1111/pace.12342. Epub 2014 Jan 27.
10
Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.植入式心脏复律除颤器用于恰加斯心脏病二级预防的长期随访。
Am J Cardiol. 2012 Oct 1;110(7):1040-5. doi: 10.1016/j.amjcard.2012.05.040. Epub 2012 Jun 20.
Zotero 插件